Baudax Bio, Inc. (BXRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Baudax Bio Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -2.507M |
| June 30, 2023 | -3.643M |
| March 31, 2023 | -4.664M |
| December 31, 2022 | -3.783M |
| September 30, 2022 | -14.00M |
| June 30, 2022 | 3.417M |
| March 31, 2022 | -13.42M |
| December 31, 2021 | -12.65M |
| September 30, 2021 | -12.57M |
| June 30, 2021 | -10.05M |
| March 31, 2021 | -14.00M |
| December 31, 2020 | -14.63M |
| Date | Value |
|---|---|
| September 30, 2020 | -11.80M |
| June 30, 2020 | -11.31M |
| March 31, 2020 | -6.314M |
| December 31, 2019 | -7.94M |
| September 30, 2019 | -2.946M |
| June 30, 2019 | -24.70M |
| March 31, 2019 | -14.46M |
| December 31, 2018 | -12.90M |
| September 30, 2018 | -15.58M |
| June 30, 2018 | -13.98M |
| March 31, 2018 | -17.29M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
| Veru, Inc. | -5.467M |
| Johnson & Johnson | 8.616B |
| Eli Lilly & Co. | 10.69B |